ProAssurance Corporation (PRA)
| Market Cap | 1.27B +7.8% |
| Revenue (ttm) | 1.10B -3.7% |
| Net Income | 65.20M +54.1% |
| EPS | 1.26 +52.1% |
| Shares Out | 51.61M |
| PE Ratio | 19.64 |
| Forward PE | 23.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 864,957 |
| Open | 24.60 |
| Previous Close | 24.60 |
| Day's Range | 24.60 - 24.79 |
| 52-Week Range | 22.72 - 24.85 |
| Beta | 0.05 |
| Analysts | Hold |
| Price Target | 25.00 (+1.22%) |
| Earnings Date | May 5, 2026 |
About PRA
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. It operates through three segments: Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Corporate. The company offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions,... [Read more]
Financial Performance
In 2025, ProAssurance's revenue was $1.11 billion, a decrease of -3.04% compared to the previous year's $1.14 billion. Earnings were $50.92 million, a decrease of -3.47%.
Financial StatementsAnalyst Summary
According to one analyst, the rating for PRA stock is "Hold" and the 12-month stock price target is $25.0.
News
ProAssurance Reports Results for First Quarter 2026
BIRMINGHAM, Ala,--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of ...
ProAssurance reports Q4 adjusted EPS 82c, consensus 25c
Reports Q4 revenue $201.52M, consensus $261.08M. “We continue to see progress toward our objectives,” said Ned Rand, President and CEO of ProAssurance (PRA). “Joining forces with The Doctors Company t...
ProAssurance Reports Results for Fourth Quarter and Full-Year 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of ...
ProAssurance reports Q3 adjusted EPS 15c, consensus 26c
Reports Q3 revenue $279.55M, consenesus $268.71M. “Our history in medical professional liability has taught us that our focused efforts will be successful over the long-term in this cyclical market an...
ProAssurance Reports Results for Third Quarter 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of ...
ProAssurance reports Q2 EPS 52c, consensus 21c
Reports Q2 revenue $276.8M, consensus $265.8M. The company said, “The quarter again illustrated benefits from our focus on ongoing actions to achieve sustained profitability, including price adequacy,...
ProAssurance Reports Results for Second Quarter 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of ...
The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
NAPA, Calif. & BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Doctors Company, the nation's largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading s...
ProAssurance stockholders approve proposed acquisition by The Doctors Company
ProAssurance (PRA) Corporation announced that stockholders have voted overwhelmingly to approve its proposed acquisition by The Doctors Company. More than 99% of shares voted were in favor of the prop...
ProAssurance Stockholders Approve Its Proposed Acquisition by The Doctors Company
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA) today announced that stockholders have voted overwhelmingly to approve its proposed acquisition by The Doctors Company. More tha...
ProAssurance price target raised to $25 from $18 at Piper Sandler
Piper Sandler analyst Paul Newsome raised the firm’s price target on ProAssurance (PRA) to $25 from $18 and keeps a Neutral rating on the shares. The firm notes the company
ProAssurance reports Q1 EPS 13c, consensus 20c
Reports Q1 revenue $272.079M, consensus $272.85M. “Our history in medical professional liability has taught us that our focused efforts will be successful over the long-term in this cyclical market,” ...
ProAssurance Reports Results for First Quarter 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported a net loss of ...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Radius Recycling, Inc. (Nasdaq - RDUS), Vacasa, Inc. (Nasdaq - VCSA), ProAssurance Corporation (NYSE - PRA)
BALA CYNWYD, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (...
ProAssurance downgraded to Underperform from Market Perform at Raymond James
Raymond James downgraded ProAssurance (PRA) to Underperform from Market Perform without a price target The firm sees limited upside in the stock price over the next 12 months while the
ProAssurance downgraded to Market Perform from Outperform at Citizens JMP
Citizens JMP analyst Matthew Carletti downgraded ProAssurance (PRA) to Market Perform from Outperform without a price target following the announcement that the company will be acquired by The Doctors...
PROASSURANCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ProAssurance Corporation - PRA
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ProAs...
The Doctors Co. to Buy ProAssurance for $1.3 Billion
The transaction is set to close in the first half of 2026 and still must be approved by ProAssurance stockholders.
AM Best Comments on Credit Ratings of ProAssurance Group Members and ProAssurance Corporation Following Announced Acquisition by The Doctors Company Insurance Group
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of “a+” (Excellent) of the members of Pro...
AM Best Comments on Credit Ratings of The Doctors Company Insurance Group Members Following Announced Acquisition of ProAssurance Corporation
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of t...
The Doctors Company to buy medical insurer ProAssurance for about $1.3 billion
The Doctors Company, a medical malpractice insurer, said on Wednesday that it has entered into an agreement to acquire ProAssurance for about $1.3 billion.
ProAssurance to be acquired by The Doctors Company for $25 per share or $1.3B
The Doctors Company and ProAssurance (PRA) Corporation announced that they have entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company. Under the terms of